FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
CVBF CEO, Donato Bonifazi, Re-elected to AICRO Board, Continuing Commitment to Clinical Research Collaboration
Donato Bonifazi, our CEO, has been elected as a board member at AICRO (Italian Association of Clinical Research Organizations). Donato Bonifazi is [...]
iCAN 2024 Advocacy and Research Summit
We are thrilled to announce that the 2024 iCAN Advocacy and Research Summit will take placefrom July 15-19 in Bari, Italy. As [...]
EJP RD Final Conference
The EJP RD Final Conference “Consolidating the Rare Disease Research Ecosystem” is scheduled to take place from May 27th to May 28th, [...]
Navigating ATMP Submissions to CTIS: Insights from CVBF’s Experts at EUCROF24
On Monday, 19 February 2024, at the EUCROF24 conference in Prague our Head of Development Area, Arianna Bertolani, takes the [...]
New Whitepaper Highlights Potential of Cell Therapy to Revolutionize Faecal Incontinence Treatment
A new whitepaper published on 7 December 2023, in the Journal of Cell and Gene Therapy Insights is bringing attention [...]
Newsletter, December 2023
Newsletter, December 2023 Starting the new year in a larger, more accessible office at Viale Cesare Battisti 17, Pavia [...]
CVBF’s CEO, selected as Permanent Member of the Advisory Group of the ACT EU Multistakeholder Platform (MSP AG)
On 20 December 2023, Donato Bonifazi, our CEO, has been selected as a permanent member of the Advisory Group [...]
Quality Assurance Head, Mariagrazia Felisi, Leads Workshop on EU Clinical Trial Regulation
On 27 June 2023, Mariagrazia Felisi, our Quality Assurance Head and Internal Auditor, co-chairing the "AICRO Clinical Trial Center Working Group", opened and led the [...]
Advanced Therapies: A Researcher’s Perspective on ATMPs – Insights from Giovanni Migliaccio
Giovanni Migliaccio, the Scientific Director of CVBF, recently participated at the MEP Interest Group 2023 Conference organized by the European Alliance for Transformative Therapies (TRANSFORM) [...]
EUCROF Paediatric Training: Our CEO’s Vision for Advancing Paediatric Clinical Research
In the ever-advancing world of clinical research, staying at the forefront of knowledge and practices is imperative. On 12 September 2023, our CEO, Donato Bonifazi [...]
Developed tools for Rare Diseases researchers – ERICA & EJP RD Joint Conference
Bonka Georgieva, CVBF's Project Manager, presented at the "ERICA & EJP RD Joint Conference" held in Amsterdam. The event served as a platform for advancing [...]
XVI Foresight Training Course
Arianna Bertolani, our Head of Project and Development, will participate, as a speaker at the 16th Foresight Training Course entitled "Repurposing to cover unmet needs: [...]
CVBF’s Expertise in Phase I Clinical Trials: A Commitment to Excellence
Phase 1 trials, be they conducted on healthy volunteers or patients, focus on generation of initial knowledge on tolerability, safety and PK/PD.. These trials determine [...]